Proof of Mechanism of Antisense Drugs
- 1 January 1996
- journal article
- review article
- Published by Mary Ann Liebert Inc in Antisense and Nucleic Acid Drug Development
- Vol. 6 (2) , 145-147
- https://doi.org/10.1089/oli.1.1996.6.145
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Sequence context of antisense RelA/NF-kB phosphorothioates determines specificityNucleic Acids Research, 1995
- Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.Proceedings of the National Academy of Sciences, 1994
- Gene inhibition using antisense oligodeoxynucleotidesNature, 1994
- Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early regionAntimicrobial Agents and Chemotherapy, 1993
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Antisense oligonucleotides as antiviral agentsTrends in Biotechnology, 1992
- Therapeutic Applications of OligonucleotidesAnnual Review of Pharmacology and Toxicology, 1992
- Suppressant effects of conventional beta blockers and sotalol on complex and repetitive ventricular premature complexesThe American Journal of Cardiology, 1990
- Pharmacology, pharmacodynamics and pharmacokinetics of sotalolPublished by Elsevier ,1990
- Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues.Proceedings of the National Academy of Sciences, 1989